ALIPAY
Ahead of 2023 International Museum Day, Digital to Asia, an Italian digital marketing agency focused on Chinese market, and Way Experience, an Italian production company that creates unique AR and VR immersive experiences for the culture and tourism sectors, today announced the launch of an innovative virtual tour featuring Leonardo da Vinci’s art on Alipay, the leading digital open platform in China.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230515005914/en/
A virtual museum launched by Italian companies on Alipay platform, exhibiting Leonardo da Vinci’s works displayed across different museums around the world (Photo: Business Wire)
The tour, with a 360-degree view powered by immersive 3D technologies, allows Chinese art lovers to see and learn about Leonardo da Vinci’s works that are displayed across different museums around the world into a single virtual museum. Italian designers and creatives took inspiration from European Renaissance architecture for the look and feel of the virtual museum. The virtual museum also includes a Chinese language guide of Leonardo da Vinci’s life and his most iconic paintings such as the Mona Lisa and The Last Supper, as well as his inventions, such as the flying machine, collected from Codex Atlanticus.
Chinese art lovers can purchase the tour through a mini program, named Yunshang Mibao, on the Alipay platform.
The virtual museum on Alipay is the latest example of how technology is being used to bring history and culture to life for a new generation of consumers. By partnering with Alipay, Digital to Asia and Way Experience are able to offer Chinese art lovers a unique and immersive experience that would not be possible otherwise.
“Emerging technologies give us the opportunity to create virtual places and travel inside them to discover humanity's greatest masterpieces. We are excited to partner with the Alipay platform to bring innovative sight-seeing experiences to Chinese consumers,” said Marco Pizzoni, co-founder and CEO of Way Experience, “Together with Digital to Asia, we created a virtual tour of Leonardo da Vinci’s masterpieces for Chinese art lovers in a Renaissance-like museum with inspiration drawn from different places that represent Italian history.”
“As an agency specializing in digital marketing strategies for Asian markets, we always stay ahead of the curve. Given mobile-savvy Chinese consumers’ open attitude towards new and innovative experiences, we have been working with Italian partner Way Experience and leading platform Alipay for the past several months to provide users with a Leonard da Vinci themed virtual tour that they have never experienced before,” said Giuliana Zagarella, General Manager of Digital to Asia. “Alipay’s deep connection with users and the availability of various digital tools on the platform make it the perfect platform partner for us in China.”
“Digital technology is making it possible for people to transcend the limitations of time and space and experience different cultures and art from all over the world. As a platform, Alipay is committed to supporting businesses to better engage with digital savvy audiences,” said Nicole Wang, Alipay’s digital solution expert for the museum industry.
The culture and tourism industries are becoming increasingly digital, with companies using more digital solutions to create new experiences for customers. According to a survey by Accenture, senior travel industry executives believe that technology is becoming more important in developing long-term business success1.
By the end of 2022, more than 2,000 museums have been using the Alipay platform to improve their digital operations and connect with museum enthusiasts, particularly younger, mobile-savvy generations. These museums leverage digital tools and services offered on Alipay, such as mini-programs, lifestyle accounts, live streaming, and blockchain-based digital collectibles to improve engagement with visitors.
According to OECD’s Tourism Trends and Policies report in 20222, “Digital technologies present wide-reaching opportunities to facilitate increased reach to consumers, productivity, and the transition to a more sustainable and inclusive future, delivering benefits to micro and small businesses and local communities as well as to visitors”.
About Way Experience
Founded in 2019, Way Experience is an Italian production company that creates unique AR and VR immersive experiences for the culture and tourism sectors. Way Experience comes up with, produces and shares innovative projects designed for the general public through both phygital experiences and full digital products. We are a team of digital creatives, storytellers and virtual artists whose mission is sharing culture, knowledge and beauty through disruptive experiences that enrich everyone who lives them.
About Digital to Asia (Branding Records Group)
Digital to Asia is a digital marketing agency founded in 2017 that supports European Brands in promoting products and services towards Chinese customers. Digital to Asia designs digital marketing strategies for Asian markets with significant and measurable results, starting from market analysis, defining sales and communications strategies and searching for suitable Chinese partners to develop online sales and brand promotions. Moreover, Digital to Asia is expert on travel marketing, with the aim to guide Chinese customers discover European attractions while ensuring the most amazing lifestyle and luxury shopping experiences.
About Alipay
In the digital era, Alipay has evolved from a trusted payment tool to an open platform that connects businesses, institutions, service providers, and other partners with consumers. Alipay enables partners from various industries to offer safe and convenient payment options. It also enables partners to communicate and deliver different digital services to their customers in China through Alipay mini programs, lifestyle accounts and other tools. The Alipay platform has connected over 80 million businesses with more than one billion consumers.
____________________________
1 https://www.accenture.com/content/dam/accenture/final/industry/travel/document/Travel-Technology-Vision-2022.pdf
2 https://www.oecd.org/cfe/tourism/oecd-tourism-trends-and-policies-20767773.htm
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230515005914/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 202518.10.2025 13:00:00 CEST | Press release
– Vimseltinib demonstrated statistically significant and clinically meaningful benefit vs placebo in antitumor response – Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the two-year efficacy and safety results from its MOTION Phase 3 study of vimseltinib in patients with TGCT in cases where surgical removal of the tumor is not an option will be presented as a poster during the 2025 European Society for Medical Oncology Congress (ESMO), taking place October 17-21 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251018921529/en/ “These long-term Phase 3 MOTION results add to the established body of evidence supporting vimseltinib as a best-in-class treatment for TGCT,” said Matthew L. Sherman, M.D., Chief Medical Officer of Deciphera. “TGCT often causes debilitating pain, stiffness and impaired mobility and these results demonstrate the dura
ProAmpac Acquires International Paper’s Bag Converting Operations17.10.2025 16:09:00 CEST | Press release
ProAmpac, a global leader in flexible packaging and material science, has acquired the bag converting operations of International Paper (“IP”), a global leader in sustainable packaging. The acquisition expands ProAmpac’s converting capabilities, further advancing the company’s Fiberization of Packaging® strategy and enhancing its ability to deliver customized bag solutions for the grocery, convenience store, and quick-service restaurant markets. “Global demand for reliable, recyclable paper packaging continues to grow rapidly amid evolving consumer expectations and market trends redefining recyclability,” stated Greg Tucker, ProAmpac founder, vice chairman, and chief executive officer. “ProAmpac’s acquisition of IP’s bag operation supports our Fiberization of Packaging initiatives, helping us better serve customers by extending our expertise in material science to the US west coast with additional capabilities and redundancies,” continued Tucker. “IP’s bag business is strong, being bui
Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT17.10.2025 16:00:00 CEST | Press release
With median follow-up of 14.3 months, pimicotinib demonstrated increasing ORR over time, from 54% at Week 25 to 76.2%Global Phase 3 MANEUVER study demonstrated ongoing improvements in key secondary endpoints including pain and functionApplication for marketing authorization under review by China National Medical Products Administration (NMPA), with additional applications planned in the U.S. and other marketsNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., for the treatment of patients with tenosynovial giant cell tumor (TGCT). This latest analysis showed that, with a median follow-up of 14.3 months, the objective response rate (ORR) for people treated with pimicotinib from the beginning of the stud
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week17.10.2025 15:04:00 CEST | Press release
- Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year - - Second pivotal development program of povetacicept underway with Phase 2b/3 trial initiation in primary membranous nephropathy - - Updated data from RUBY-3 trial of povetacicept accepted for late breaking oral presentation; inaxaplin study design and APOL1-mediated kidney disease related data accepted for poster presentation - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein therapeutic and dual antagonist of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines. Pove has demonstrated best-in-class potential in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) and has pipeline-in-a-product potential across a range of B c
Qualcomm Announces Quarterly Cash Dividend17.10.2025 15:00:00 CEST | Press release
Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.89 per common share, payable on December 18, 2025, to stockholders of record at the close of business on December 4, 2025. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built with our leading-edge AI, high-performance, low-power computing, and unrivaled connectivity. Our Snapdragon® platforms power extraordinary consumer experiences, and our Qualcomm Dragonwing™ products empower businesses and industries to scale to new heights. Together with our ecosystem partners, we enable next-generation digital transformation to enrich lives, improve businesses, and advance societies. At Qualcomm, we are engineering human progress. Qualcomm Incorporated includes our licensing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom